S&P 500

5.308,13

0,09%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Micro Therapeutics (MM) (MTIX)
Micro Therapeutics (MM) (MTIX) Notícias

MTIX

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MTIX

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/12/2005	14:01	PR Newswire (US)	ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
14/11/2005	12:11	PR Newswire (US)	ev3 Inc. and Micro Therapeutics, Inc. Announce Merger Agreement	NASDAQ:MTIX	Micro Therapeutics (MM)
27/10/2005	11:01	PR Newswire (US)	Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net Sales	NASDAQ:MTIX	Micro Therapeutics (MM)
27/10/2005	11:00	PR Newswire (US)	ev3 Inc. Reports Third Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
21/10/2005	12:00	PR Newswire (US)	ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
10/10/2005	11:30	PR Newswire (US)	ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
10/10/2005	10:30	PR Newswire (US)	Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
05/10/2005	15:04	PR Newswire (US)	Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
02/08/2005	18:51	PR Newswire (US)	Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
02/08/2005	18:48	PR Newswire (US)	ev3 Inc. Reports Second Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
27/07/2005	17:27	PR Newswire (US)	ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
21/07/2005	19:27	PR Newswire (US)	ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder	NASDAQ:MTIX	Micro Therapeutics (MM)
21/07/2005	19:08	PR Newswire (US)	Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder	NASDAQ:MTIX	Micro Therapeutics (MM)
06/07/2005	19:30	PR Newswire (US)	Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
28/04/2005	18:14	PR Newswire (US)	Micro Therapeutics Reports 50% Net Sales Increase for 2005 First Quarter	NASDAQ:MTIX	Micro Therapeutics (MM)
25/04/2005	14:28	PR Newswire (US)	Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
21/03/2005	18:57	PR Newswire (US)	ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical Trial	NASDAQ:MTIX	Micro Therapeutics (MM)
10/02/2005	18:23	PR Newswire (US)	Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
10/02/2005	10:45	PR Newswire (US)	Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February	NASDAQ:MTIX	Micro Therapeutics (MM)
07/02/2005	21:40	PR Newswire (US)	Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
01/02/2005	10:00	PR Newswire (US)	Micro Therapeutics Receives $3.7 Million Payment	NASDAQ:MTIX	Micro Therapeutics (MM)
29/12/2004	15:13	PR Newswire (US)	Micro Therapeutics Consolidates Manufacturing Capabilities	NASDAQ:MTIX	Micro Therapeutics (MM)
06/12/2004	18:04	PR Newswire (US)	ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical Trial	NASDAQ:MTIX	Micro Therapeutics (MM)
10/11/2004	12:00	PR Newswire (US)	ev3 International Files Lawsuit Against Distributors in Hong Kong and Phoenix	NASDAQ:MTIX	Micro Therapeutics (MM)
04/11/2004	10:00	PR Newswire (US)	Micro Therapeutics Reports 2004 Third Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
01/11/2004	17:24	PR Newswire (US)	Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4	NASDAQ:MTIX	Micro Therapeutics (MM)
21/10/2004	12:47	PR Newswire (US)	FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long Stents	NASDAQ:MTIX	Micro Therapeutics (MM)
21/09/2004	10:01	PR Newswire (US)	ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft Use	NASDAQ:MTIX	Micro Therapeutics (MM)
26/08/2004	13:33	PR Newswire (US)	ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting Procedures	NASDAQ:MTIX	Micro Therapeutics (MM)
18/08/2004	14:51	PR Newswire (US)	Micro Therapeutics Completes Issuance of Common Stock for Exchangeable Notes	NASDAQ:MTIX	Micro Therapeutics (MM)